DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, supplying promising developments across several health-related and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, additional reliable option for therapeutic use, no